Ready-Made immune cells take on Hard-to-Treat cancers
NCT ID NCT07216105
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This early-stage study tests a new cancer treatment called FT836, which uses donor immune cells specially designed to attack tumors. It is for people with advanced lung, colorectal, breast, ovarian, endometrial, or head and neck cancers that have not responded to standard treatments. The study aims to find the safest dose and check if combining FT836 with chemotherapy or other antibodies is tolerable and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M. D. Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
-
Thomas Jefferson University, Sidney Kimmel Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
Contact
-
UC San Diego Moores Cancer Center
RECRUITINGLa Jolla, California, 92093, United States
-
University of Minnesota Masonic Cancer Center
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact
-
University of Southern California
RECRUITINGLa Jolla, California, 90033, United States
Conditions
Explore the condition pages connected to this study.